[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"status-days":3,"stock-4174":32,"stock-themes-4174":135,"stock-fin-4174":230},[4,18],{"date":5,"taiex_close":6,"taiex_chg":7,"taiex_chg_pct":8,"advancers":9,"decliners":10,"unchanged":11,"stocks":12,"turnover_sum":13,"margin_balance":14,"margin_chg":15,"short_balance":16,"short_chg":17},"2026-10-12",49301.96,-11.480000000003201,-0.00023279657634922568,868,916,158,1971,1044705369816,9174215,2895,175930,1165,{"date":19,"taiex_close":20,"taiex_chg":21,"taiex_chg_pct":22,"advancers":23,"decliners":24,"unchanged":25,"stocks":26,"turnover_sum":27,"margin_balance":28,"margin_chg":29,"short_balance":30,"short_chg":31},"2026-10-13",48341.31,-960.6500000000015,-0.019485026558781926,444,1337,161,1975,1306098703553,9070158,-104057,168869,-7061,{"profile":33,"snapshot":50,"data_version":134},{"code":34,"name":35,"full_name":36,"market":37,"kind":38,"industry":39,"listed_date":40,"chairman":41,"president":42,"capital":43,"shares":44,"founded_date":45,"website":46,"address":47,"english_name":48,"dividend_frequency":49},"4174","浩鼎","台灣浩鼎生技股份有限公司","otc","stock","生技醫療業","2015-03-23","梁賡義","陳雅琪",1315796870,131579687,"2002-04-29","https:\u002F\u002Fwww.obipharma.com","(115011)台北市南港區忠孝東路7段508號6樓","OBI","每年",{"code":34,"name":35,"market":37,"kind":38,"industry":39,"close":51,"chg":52,"chg_pct":53,"ret_5d":54,"ret_20d":55,"volume":56,"turnover":57,"mcap":58,"signals":59,"as_of":19,"ref_price":61,"ret_60d":62,"ret_ytd":63,"open":64,"high":65,"low":66,"pe":67,"pb":68,"dy":69,"foreign_net_1d":70,"foreign_net_5d":71,"trust_net_1d":69,"trust_net_5d":69,"dealer_net_1d":69,"dealer_net_5d":69,"foreign_holding_pct":72,"margin_balance":73,"margin_chg":74,"short_balance":75,"short_chg":76,"large_holder_pct":77,"large_holder_chg_1w":78,"large_holder_chg_4w":79,"holders_date":80,"high_52w":81,"low_52w":82,"rev_period":83,"rev_yoy":84,"eps_period":85,"eps":86,"spark":87},55.8,-1.7000000000000028,-0.029565217391304355,0.20779220779220764,1.1338432122370938,787463,43742268,7342146534.599999,[60],"eps_yoy",57.5,0.9476439790575917,0.033333333333333215,56.9,57.6,54,null,4.94,0,-92000,-796960,7.11,1360,-95,120,3,36.21,-1.2299999999999969,2.4200000000000017,"2026-10-09",58.9,22.85,"2026-09",-69.68,"2026-Q2",-2.043620710489536,[88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,102,95,103,100,104,105,102,106,107,108,108,95,109,110,111,100,112,113,114,115,113,116,117,118,100,119,98,117,120,92,121,122,123,124,125,126,127,128,129,130,131,132,133,61,51],27.7,28.25,27.9,28.05,27.75,27.55,27.1,26.3,25.55,24.9,25.1,26.85,26.15,26.25,25.95,26.55,26.75,26.35,25.75,25.6,26.9,26.1,26.7,26.4,25.4,25.05,25,24.6,24.95,26,26.45,25.45,26.65,27.2,29.9,29.65,32.6,32.45,35.65,39.2,43.1,42,46.2,50.8,52.1,53.7,"20261013-fcba10",[136],{"theme":137,"segment":145,"tier":146,"role":147,"relevance":148,"note":149,"peers":150,"upstream":222,"downstream":229},{"id":138,"slug":139,"name":140,"category":141,"ret_1d":144},55,"new-drugs","新藥研發",{"slug":142,"name":143},"biotech","生技醫療",-0.025792561311777984,"新藥開發與臨床","upstream","challenger","high","癌症新藥開發",[151,166,179,190,201,212],{"code":152,"name":153,"role":154,"relevance":148,"note":155,"industry":39,"close":17,"chg_pct":156,"ret_5d":157,"ret_20d":158,"mcap":159,"turnover":160,"signals":161},"6446","藥華藥","leader","血液疾病新藥，已有上市產品",-0.016877637130801593,-0.021008403361344352,-0.11742424242424243,492134794500,1315551970,[162,163,60,164,165],"rev_yoy","rev_yoy_3m","trust_buy_5d","holders_up",{"code":167,"name":168,"role":169,"relevance":148,"note":170,"industry":39,"close":171,"chg_pct":172,"ret_5d":173,"ret_20d":174,"mcap":175,"turnover":176,"signals":177},"4743","合一","niche","傷口與皮膚新藥",47.55,-0.03451776649746208,0.009554140127388422,0.04390779363336983,22849367925,83204957,[60,178,165],"foreign_buy_5d",{"code":180,"name":181,"role":169,"relevance":148,"note":182,"industry":39,"close":183,"chg_pct":184,"ret_5d":185,"ret_20d":186,"mcap":187,"turnover":188,"signals":189},"4147","中裕","愛滋病抗體藥，已有上市產品",58.3,-0.036363636363636376,-0.028333333333333433,-0.0535714285714286,15927699919.999998,72544406,[],{"code":191,"name":192,"role":169,"relevance":148,"note":193,"industry":39,"close":194,"chg_pct":195,"ret_5d":196,"ret_20d":197,"mcap":198,"turnover":199,"signals":200},"4162","智擎","新藥開發與授權",56.5,-0.013961605584642212,0.027272727272727337,0.031021897810219023,8230784400,14152607,[162,60],{"code":202,"name":203,"role":169,"relevance":204,"note":205,"industry":39,"close":66,"chg_pct":206,"ret_5d":207,"ret_20d":208,"mcap":209,"turnover":210,"signals":211},"1760","寶齡富錦","mid","腎臟病用藥與保健品",-0.021739130434782594,0.0018552875695734272,-0.018181818181818077,4629906702,4998637,[162,60,178],{"code":213,"name":214,"role":147,"relevance":148,"note":149,"industry":39,"close":215,"chg_pct":216,"ret_5d":217,"ret_20d":218,"mcap":219,"turnover":220,"signals":221},"6550","北極星藥業-KY",15.9,-0.027522935779816682,-0.01851851851851838,-0.19039113027409926,14227203930.000002,8240813,[60,178,165],[223],{"id":224,"slug":225,"name":226,"category":227,"ret_1d":228},56,"cdmo-generics","CDMO 與學名藥",{"slug":142,"name":143},-0.010249642314885767,[],{"code":34,"revenue":231,"quarters":408},[232,236,240,245,250,255,260,265,270,275,280,285,290,295,300,305,310,315,320,325,330,335,340,345,350,355,360,365,370,375,380,385,390,395,400,405],{"period":233,"revenue":234,"yoy_pct":67,"mom_pct":235},"2023-10",4769,-11.09,{"period":237,"revenue":238,"yoy_pct":67,"mom_pct":239},"2023-11",6531,36.94,{"period":241,"revenue":242,"yoy_pct":243,"mom_pct":244},"2023-12",7119,1301.37,9,{"period":246,"revenue":247,"yoy_pct":248,"mom_pct":249},"2024-01",1429,2451.78,-79.92,{"period":251,"revenue":252,"yoy_pct":253,"mom_pct":254},"2024-02",4477,6118.05,213.29,{"period":256,"revenue":257,"yoy_pct":258,"mom_pct":259},"2024-03",3229,94.75,-27.87,{"period":261,"revenue":262,"yoy_pct":263,"mom_pct":264},"2024-04",4282,3828.44,32.61,{"period":266,"revenue":267,"yoy_pct":268,"mom_pct":269},"2024-05",6684,271.33,56.09,{"period":271,"revenue":272,"yoy_pct":273,"mom_pct":274},"2024-06",8050,1.14,20.43,{"period":276,"revenue":277,"yoy_pct":278,"mom_pct":279},"2024-07",12374,293.82,53.71,{"period":281,"revenue":282,"yoy_pct":283,"mom_pct":284},"2024-08",5945,100.16,-51.95,{"period":286,"revenue":287,"yoy_pct":288,"mom_pct":289},"2024-09",4660,-13.12,-21.61,{"period":291,"revenue":292,"yoy_pct":293,"mom_pct":294},"2024-10",1753,-63.24,-62.38,{"period":296,"revenue":297,"yoy_pct":298,"mom_pct":299},"2024-11",1953,-70.09,11.4,{"period":301,"revenue":302,"yoy_pct":303,"mom_pct":304},"2024-12",7842,10.15,301.53,{"period":306,"revenue":307,"yoy_pct":308,"mom_pct":309},"2025-01",555,-61.16,-92.92,{"period":311,"revenue":312,"yoy_pct":313,"mom_pct":314},"2025-02",10979,145.23,1878.19,{"period":316,"revenue":317,"yoy_pct":318,"mom_pct":319},"2025-03",2924,-9.44,-73.36,{"period":321,"revenue":322,"yoy_pct":323,"mom_pct":324},"2025-04",5132,19.85,75.51,{"period":326,"revenue":327,"yoy_pct":328,"mom_pct":329},"2025-05",3747,-43.94,-26.98,{"period":331,"revenue":332,"yoy_pct":333,"mom_pct":334},"2025-06",3879,-51.81,3.52,{"period":336,"revenue":337,"yoy_pct":338,"mom_pct":339},"2025-07",4105,-66.82,5.82,{"period":341,"revenue":342,"yoy_pct":343,"mom_pct":344},"2025-08",1067,-82.05,-74,{"period":346,"revenue":347,"yoy_pct":348,"mom_pct":349},"2025-09",5350,14.8,401.4,{"period":351,"revenue":352,"yoy_pct":353,"mom_pct":354},"2025-10",5522,215,3.21,{"period":356,"revenue":357,"yoy_pct":358,"mom_pct":359},"2025-11",7934,306.24,43.67,{"period":361,"revenue":362,"yoy_pct":363,"mom_pct":364},"2025-12",7381,-5.87,-6.97,{"period":366,"revenue":367,"yoy_pct":368,"mom_pct":369},"2026-01",1333,140.18,-81.94,{"period":371,"revenue":372,"yoy_pct":373,"mom_pct":374},"2026-02",1593,-85.49,19.5,{"period":376,"revenue":377,"yoy_pct":378,"mom_pct":379},"2026-03",2638,-9.78,65.59,{"period":381,"revenue":382,"yoy_pct":383,"mom_pct":384},"2026-04",3448,-32.81,30.7,{"period":386,"revenue":387,"yoy_pct":388,"mom_pct":389},"2026-05",1516,-59.54,-56.03,{"period":391,"revenue":392,"yoy_pct":393,"mom_pct":394},"2026-06",10316,165.94,580.47,{"period":396,"revenue":397,"yoy_pct":398,"mom_pct":399},"2026-07",4081,-0.58,-60.44,{"period":401,"revenue":402,"yoy_pct":403,"mom_pct":404},"2026-08",817,-23.43,-79.98,{"period":83,"revenue":406,"yoy_pct":84,"mom_pct":407},1622,98.53,[409,416,423,430,437,444,451,458,465,472,479,486],{"period":410,"eps":411,"gross_margin":412,"operating_margin":413,"net_margin":414,"roe":415},"2023-Q3",-2.6739740428191494,-186.99895433949112,-5385.1080515859185,-5346.070059254095,-10.5931372997605,{"period":417,"eps":418,"gross_margin":419,"operating_margin":420,"net_margin":421,"roe":422},"2023-Q4",-2.4664944207490085,-77.14316738150822,-2642.613605516043,-3072.4306422715676,-10.821113208748583,{"period":424,"eps":425,"gross_margin":426,"operating_margin":427,"net_margin":428,"roe":429},"2024-Q1",-2.4719163317198354,-286.44772851669404,-6245.801860974275,-6208.593322386426,-12.121526232352316,{"period":431,"eps":432,"gross_margin":433,"operating_margin":434,"net_margin":435,"roe":436},"2024-Q2",-2.5674884087039977,-73.20677324358435,-2866.980437526294,-3097.8281447202357,-14.090376671920113,{"period":438,"eps":439,"gross_margin":440,"operating_margin":441,"net_margin":442,"roe":443},"2024-Q3",-2.448555043292477,-65.62078419426433,-2324.1089690587055,-2444.8191827320597,-15.250238609452518,{"period":445,"eps":446,"gross_margin":447,"operating_margin":448,"net_margin":449,"roe":450},"2024-Q4",-2.943512563108139,-182.776238309664,-6249.844128853481,-6707.767578801524,-18.82213237622153,{"period":452,"eps":453,"gross_margin":454,"operating_margin":455,"net_margin":456,"roe":457},"2025-Q1",-2.090444042660076,-111.9311108037073,-3537.1766496057544,-3804.952275556785,-12.094982062107377,{"period":459,"eps":460,"gross_margin":461,"operating_margin":462,"net_margin":463,"roe":464},"2025-Q2",-2.674177703703535,-182.05047813136855,-5358.253644771908,-5516.029158175263,-17.954534959340883,{"period":466,"eps":467,"gross_margin":468,"operating_margin":469,"net_margin":470,"roe":471},"2025-Q3",-1.9730247142986344,-211.58524995248052,-4719.730089336628,-4934.613191408477,-15.631559782617693,{"period":473,"eps":474,"gross_margin":475,"operating_margin":476,"net_margin":477,"roe":478},"2025-Q4",-3.6759393736267825,-76.10020636367999,-2289.988961942698,-2321.2506598838604,-16.66238060534573,{"period":480,"eps":481,"gross_margin":482,"operating_margin":483,"net_margin":484,"roe":485},"2026-Q1",-3.826555312103615,-497.411933860532,-8166.822429906541,-9049.191229331416,-20.282972313074275,{"period":85,"eps":86,"gross_margin":487,"operating_margin":488,"net_margin":489,"roe":490},-90.81151832460733,-1380.6675392670156,-1759.8102094240837,-12.129029173378104]